Advanced Search

Chemical Pathology Stocks List

Symbol Grade Name % Change
MYGN A Myriad Genetics, Inc. 0.86
A D Agilent Technologies, Inc. -0.39
GBS F GBS Inc. -3.24
View As Page of Charts
Related Industries: Diagnostics & Research Medical Devices
Related Stock Lists: Biomarkers Clinical Medicine Diagnostic Tests Medicine Acid Analytical Chemistry Biomarker Biosensor Biotechnology Blood Glucose Monitoring Breast And Ovarian Cancer Cancer Chromatography Colorectal Cancer Companion Diagnostic Diabetes Diabetes Management Diagnostic Services Disease Electronic Commerce

Related ETFs - A few ETFs which own one or more of the above listed Chemical Pathology stocks.

Symbol Grade Name Weight
MJJ C MicroSectors Cannabis ETNs 9.9
MJO D MicroSectors Cannabis 2X Leveraged ETNs 9.9
GNOM D Global X Genomics & Biotechnology ETF 5.73
DEMZ B DEMZ Political Contributions ETF 5.04
FIW B First Trust ISE Water Index Fund 4.01
View all Chemical Pathology related ETFs...
Compare ETFs
  • Compare MJJ to DEMZ
  • Compare MJJ to GNOM
  • Compare MJO to FIW

    • Recent Signals

    Date Stock Signal Type
    2021-02-25 A Fell Below 20 DMA Bearish
    2021-02-25 A 180 Bearish Setup Bearish Swing Setup
    2021-02-25 A Fell Below 50 DMA Bearish
    2021-02-25 GBS Lower Bollinger Band Walk Weakness
    2021-02-25 GBS New 52 Week Low Weakness
    2021-02-25 GBS New 52 Week Closing Low Bearish
    2021-02-25 MYGN Shooting Star Candlestick Bearish
    2021-02-25 MYGN New 52 Week High Strength
    2021-02-25 MYGN Bollinger Band Squeeze Range Contraction
    2021-02-25 MYGN Lizard Bearish Bearish Day Trade Setup

    Recent News for Chemical Pathology Stocks

    Date Stock Title
    Feb 24 MYGN Myriad Genetics Inc (MYGN) Q2 2021 Earnings Call Transcript
    Feb 24 MYGN Myriad Genetics, Inc. (MYGN) CEO Paul Diaz on Q2 2021 Results - Earnings Call Transcript
    Feb 23 MYGN Recap: Myriad Genetics Q2 Earnings
    Feb 23 MYGN Myriad Genetics EPS in-line, beats on revenue
    Feb 23 MYGN Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan
    Feb 23 MYGN The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
    Feb 23 MYGN Earnings Scheduled For February 23, 2021
    Feb 22 MYGN Myriad Genetics FQ2 2021 Earnings Preview
    Feb 22 A Agilent’s pharmDx assay approved for use in non-small cell lung cancer
    Feb 22 A Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)
    Feb 22 MYGN A Preview Of Myriad Genetics's Earnings
    Feb 20 MYGN The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
    Related Industries: Diagnostics & Research Medical Devices
    Related Stock Lists: Biomarkers Clinical Medicine Diagnostic Tests Medicine Acid Analytical Chemistry Biomarker Biosensor Biotechnology Blood Glucose Monitoring Breast And Ovarian Cancer Cancer Chromatography Colorectal Cancer Companion Diagnostic Diabetes Diabetes Management Diagnostic Services Disease Electronic Commerce

    Browse All Tags